In different primary tumours (e.g. glioma, small cell lung, renal, liver, breast, ovarian and thyroid cancers [3, 4, 54]), as well as in cancer patient plasma [55], increased ATX expression and therefore increased LPA levels were reported, suggesting LPA as a potential cancer biomarker [56]. This evidence concerns the gene ENPP2 and neoplasm.